Thomas Merigan
Overview
Explore the profile of Thomas Merigan including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
3
Citations
63
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Kagan R, Winters M, Merigan T, Heseltine P
AIDS Res Hum Retroviruses
. 2004 Mar;
20(1):1-9.
PMID: 15000693
We established a database of HIV-1 reverse transcriptase (RT) and protease (PR) sequences and mutations to monitor the prevalence of antiretroviral drug resistance and mutational patterns in clinical samples submitted...
2.
Short-term safety and antiretroviral activity of T-1249, a second-generation fusion inhibitor of HIV
Eron J, Gulick R, Bartlett J, Merigan T, Arduino R, Michael Kilby J, et al.
J Infect Dis
. 2004 Mar;
189(6):1075-83.
PMID: 14999611
T-1249 is a 39-aa synthetic peptide that inhibits fusion of human immunodeficiency virus (HIV) to the host target cell. A 14-day open-label, phase 1/2 dose-escalation monotherapy study of the safety...
3.
Qari S, Winters M, Vandamme A, Merigan T, Heneine W
Antivir Ther
. 2002 Sep;
7(2):131-9.
PMID: 12212925
Zidovudine and other nucleoside analogue reverse transcriptase inhibitors (NRTIs), like zalcitabine and didanosine used for treatment of individuals infected with HIV-1, can select for viruses with Q151M and other associated...